4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-23-034518
President and CSO sold 156,530 shares at an average $32.06 ($5,018,292)
- President and CSO acquired 92,490 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciaramella Giuseppe President and CSO | 2023-07-21 | Option exercise 10b5-1 | +69,438 | $7.22 | $501,342 | 181,728 | D |
| Ciaramella Giuseppe President and CSO | 2023-07-21 | Option exercise 10b5-1 | +21,846 | $7.22 | $157,728 | 203,574 | D |
| Ciaramella Giuseppe President and CSO | 2023-07-21 | Sale 10b5-1 | −155,324 | $32.06 | $4,979,687 | 48,250 | D |
| Ciaramella Giuseppe President and CSO | 2023-07-24 | Option exercise 10b5-1 | +1,206 | $7.22 | $8,707 | 49,456 | D |
| Ciaramella Giuseppe President and CSO | 2023-07-24 | Sale 10b5-1 | −1,206 | $32.01 | $38,604 | 48,250 | D |
| Derivatives | |||||||
| Ciaramella Giuseppe President and CSO | 2023-07-21 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −69,438 | 20,208 | D | ||
| Ciaramella Giuseppe President and CSO | 2023-07-21 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −21,846 | 1,457 | D | ||
| Ciaramella Giuseppe President and CSO | 2023-07-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,206 | 19,002 | D | ||
| Open-market sales · 156,530 sh · avg $32.06 · $5,018,292 | |||||||
Loading xslF345X05/ownership.xml…